Abbott Laboratories

NYSE: ABT
$113.70
-$0.45 (-0.4%)
Closing Price on September 20, 2024

ABT Articles

According to Reuters, the Administration has forced GM (GM) CEO Rick Wagoner out of his job. Reuters reports that in an FT interview Obama said the G-20 nations should send a strong message of unity....
LDK Solar (LDK) Write-down and poor forecast. Drops to $4.01 from 52-week high of $52.40. Abbott Laboratories (ABT) No special news. Just drifting down. Falls to $44.51 from 52-week high of $59.95....
We compiled a list of the equity holdings of the Bill & Melinda Gates Foundation and for Bill Gates’ personal investment vehicle Cascade Investment.  These are as of December 31, 2008 and we...
If we told you on Friday that a decent-sized medical merger was coming with a 100% premium, you probably wouldn’t have believed it.  We are having a hard time believing it even after the fact. ...
According to Reuters, retail sales will probably drop further after the holidays. Reuters reports that the shock waves of the Madoff scandal are spreading around the financial world. Reuters writes...
The Massachusetts Department of Public Health funded a study which is showing further evidence to support the use of drug eluting stents over bare metal stents in heart attack patients.  This study...
The stent business in the US has been dying and it is in trouble overseas. Stents are small mesh tubs which keep clogged arteries open. Last year, several studies showed that stents could cause...
There is one critical aspect to the stock market that pertains to American International Group (NYSE: AIG) which has been given less coverage because of the media’s focus on the turmoil in the...
Investors have another reason to bail out of Boston Scientific (BSX). It has been in a battle with the medical research community for over a year fighting the perception that its drug-coated stents...
We saw another exciting week full of news for key developments in drug stocks, biotech stocks, medical device stocks, and other companies involved in various aspects of health care and medicine. ...
According to Reuters, US stock indices entered a bear market phase. Reuters writes that Yahoo! (YHOO) and Microsoft (MSFT) are exploring media tie-ups with other internet companies.. Reuters reports...
With the trading year almost half over and results from the first quarter out, 24/7 Wall St. has created the latest installment of its Ten Worst Managed Companies In America list. This analysis is...
Boston Scientific (BSX) has been the "gang who couldn’t shot straight" of the medical device business for some time. It spent far too much money to buy another medical company, Guidant. For all of...
These are ten of the impact analyst calls we are seeing this Friday morning: Abbott Labs (NYSE: ABT) started as Buy at UBS. Advanced Energy (NASDAQ: AEIS) Raised To Overweight By JP Morgan. American...
Thursday after the close, we’ll get to see earnings out of Genentech (NASDAQ: DNA). The estimates from First Call are $0.82 EPS on $3.11 billion in revenues.  Next quarter estimates are $0.86 EPS...